Amicucci Matteo, Mastronuzzi Angela, Ciaralli Italo, Piccioni Federico, Schiopu Andreea Cristina, Tiozzo Emanuela, Gawronski Orsola, Biagioli Valentina, Dall'Oglio Immacolata
Department of Onco Haematology and Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.
Department of Paediatric Emergency, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.
J Clin Med. 2020 Nov 21;9(11):3756. doi: 10.3390/jcm9113756.
Despite the fact that cancer patients seem to be at a higher risk of being infected with SARS-CoV-2, limited data are available in the pediatric oncology setting. A systematic rapid review was conducted to analyze scientific literature regarding the management, interventions, and strategies adopted to prevent the spread of COVID-19 in the pediatric cancer population. Our search on PubMed, Scopus, Cochrane, and EMBASE databases yielded 505 articles. After removing duplicates, 21 articles were included. Articles focused on infection prevention ( = 19; 90.5%), management ( = 18; 85.7%), overall management of specific treatments for cancer ( = 13; 61.9%), and education ( = 7; 33.3%). The interventions adopted to prevent the spread of COVID-19 were similar across organizations and in line with general recommendations. Most of them reported interventions that could be used as valid strategies for similar emergencies. The strategies included limiting the risk of contagion by restricting access to the wards and implementing hygiene measures, the identification of separate pathways for the management of patients suspected or confirmed to be infected with COVID-19, the postponement of people accessing the hospital for non-urgent or unnecessary tests or medical examinations, and the preventive screening of patients before chemotherapy treatment or transplantation of hematopoietic stem cells. It is necessary to identify key indicators in order to better evaluate the effectiveness of the interventions implemented over time. A summary of the recommendations is provided.
尽管癌症患者似乎感染SARS-CoV-2的风险更高,但儿科肿瘤领域的相关数据有限。我们进行了一项系统的快速综述,以分析关于在儿科癌症患者中预防COVID-19传播所采取的管理、干预措施和策略的科学文献。我们在PubMed、Scopus、Cochrane和EMBASE数据库中检索到505篇文章。去除重复项后,纳入了21篇文章。文章重点关注感染预防(=19;90.5%)、管理(=18;85.7%)、癌症特定治疗的总体管理(=13;61.9%)和教育(=7;33.3%)。各机构为预防COVID-19传播所采取的干预措施相似,且符合一般建议。大多数文章报道的干预措施可作为应对类似紧急情况的有效策略。这些策略包括通过限制病房出入和实施卫生措施来降低传染风险,为疑似或确诊感染COVID-19的患者确定单独的管理路径,推迟非紧急或不必要检查或医疗的人员进入医院,以及在化疗或造血干细胞移植前对患者进行预防性筛查。有必要确定关键指标,以便更好地评估随着时间推移所实施干预措施的有效性。本文提供了建议总结。